The trajectory of Viagra presents a complex picture for shareholders. While the initial launch generated substantial gains, the lapse of its patent opened the door to cheaper alternatives, dramatically reducing market https://thefairlist.com/story11892081/viagra-and-the-pharmaceutical-industry-a-precarious-bet